Table 5.
Age Group, years | Not Accounting for BCE | Accounting for BCE |
45–54 | ||
Projected population, millions | 44.0 | 44.0 |
Projected no. of cases, millions | 5.4 | 2.7 |
Projected prevalence, % | 12.2 | 6.1 |
55–64 | ||
Projected population, millions | 40.3 | 40.3 |
Projected no. of cases, millions | 11.9 | 7.1 |
Projected prevalence, % | 29.6 | 17.7 |
65–74 | ||
Projected population, millions | 38.8 | 38.8 |
Projected no. of cases, millions | 20.3 | 15.1 |
Projected prevalence, % | 52.2 | 39.0 |
75–84 | ||
Projected population, millions | 24.6 | 24.6 |
Projected no. of cases, millions | 19.7 | 17.8 |
Projected prevalence, % | 80.0 | 72.3 |
≥85 | ||
Projected population, millions | 8.5 | 8.5 |
Projected no. of cases, millions | 8.3 | 8.2 |
Projected prevalence, % | 97.3 | 96.2 |
Total | ||
Projected population, millions | 156.2 | 156.2 |
Projected no. of cases, millions | 65.5 | 50.9 |
Projected prevalence, % | 41.9 | 32.6 |
Abbreviation: BCE, birth cohort effect.
Based on US Census data (15).